GLENMARK PHARMACEUTICALS LTD
美国出口商 · 出口 227 笔 · 主营 其他零售药品
美国 · 存续
1
进口笔数
227
出口笔数
$0
进口金额
$0
出口金额
2023-07-15
最近进口
2026-09-23
最近出口
1
供应商数
7
采购商数
近 3 年贸易趋势
主营产品(HS 编码)
进口
暂无数据
出口
| HS 编码 | 产品 |
|---|---|
| 300490 | 其他零售药品 |
| 300660 | 化学避孕药 |
| 294190 | 其他抗生素 |
| 300420 | 抗生素药品 |
| 300449 | 生物碱药品 |
主要市场
进口来源地
| 国家 / 地区 | 交易笔数 | 金额(USD) |
|---|---|---|
| 印度 | 1 | $0 |
出口目的地
| 国家 / 地区 | 交易笔数 | 金额(USD) |
|---|---|---|
| 美国 | 227 | $0 |
贸易伙伴
上游供应商(共 1)
| 企业 | 国家 | 交易笔数 | 金额(USD) | 主营产品 |
|---|---|---|---|---|
| GLENMARK PHARMACEUTICALS LIMITED | 印度 | 1 | $0 | 其他零售药品、化学避孕药 |
下游采购商(共 7)
| 企业 | 国家 | 交易笔数 | 金额(USD) | 主营产品 |
|---|---|---|---|---|
| GLENMARK PHARMACEUTICALS INC. | 美国 | 102 | $0 | 其他零售药品、化学避孕药 |
| GLENMARK PHARMACEUTICALS INC., USA | 美国 | 85 | $0 | 其他零售药品、化学避孕药 |
| GLENMARK GENERICS INC USA | 美国 | 32 | $0 | 维生素药品 |
| Glenmark Pharmaceuticals Canada Inc. | 加拿大 | 3 | $0 | 其他零售药品、化学避孕药 |
| Geodis USA, Inc. | 美国 | 2 | $0 | 纺织面料鞋、皮质类固醇药品 |
| Glenmark Pharmaceuticals s.r.o. | 捷克 | 2 | $0 | 其他零售药品、皮质类固醇药品 |
| Bausch Health Companies Inc. | 加拿大 | 1 | $0 | 其他零售药品、其他杂环化合物 |
近期贸易明细
进口(共 1)
| 日期 | 产品 | 对手方 | 国家 | 金额(USD) |
|---|---|---|---|---|
| 2023-07-15 | 4 PALLETS 123 CARTONS PHARMA CEUTICALS AS UNDER NITROGLYCE RIN SUBLING TAB 0.4MG 4X25 ND C CODE:68462063945 FDA PRODUC T CODE NO.: 66 S C A 28 H. T . S NO.: 3004.90.9020 ANDA N O.:206391 THERAPEUTIC USE: M EDICATION USED FOR HEART FAIL URE,HIGH BLOOD PRESSURE,AND T O TREAT AND PREVENT CHEST PAI N FROM NOT ENOUGH BLOOD FLOW TO THE HEART NITROGLYCERIN S UBLING TAB 0.4MG 4X25 NDC COD E:68462063945 FDA PRODUCT COD E NO.: 66 S C A 28 H. T. S N O.: 3004.90.9020 ANDA NO.:20 6391 THERAPEUTIC USE: MEDICA TION USED FOR HEART FAILURE,H IGH BLOOD PRESSURE,AND TO TRE AT AND PREVENT CHEST PAIN FRO M NOT ENOUGH BLOOD FLOW TO T HE HEART 04 DATA LOGGERS HU MIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE N O. F22487000627 DT. 30.06.202 3 F22487000646 DT. 30.06.2023 S/BILL NO:4009951 DT:04.07 .2023 S/BILL NO:4009947 DT:04 .07.2023 NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZ ERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAN D | GLENMARK PHARMACEUTICALS LIMITED | 印度 | $0 |
出口(共 227)
| 日期 | 产品 | 对手方 | 国家 | 金额(USD) |
|---|---|---|---|---|
| 2026-09-23 | 其他零售药品 | GLENMARK PHARMACEUTICALS INC., USA | 美国 | $0 |
| 2026-09-21 | 其他零售药品 | GLENMARK PHARMACEUTICALS INC., USA | 美国 | $0 |
| 2026-09-18 | 15 PACKAGES 1183 CARTONS PHARMACEUTICALS AS UNDER LACOSAMIDE TAB 100MG 60 NDC CODE68462067960 FDA XXXXXXXXXXXX NO. 61 M C A 47 H. T. SNO. 3004.90.9230 ANDA NO. 205006 THERAPEUTIC E USE LACOSAMIDE TABLETS ARE INDICATED AS ADJUNCTIVE THERAPY IN THE TREATMENT OF XXXXXXXXXSET SEIZURES IN PATIENTS WITH EPILEPSY AGED 1 7 YEARS AND OLDER. LACOSAMIDE TAB 150MG 60 NDC CODE68462068060 FDA XXXXXXXXXXXX NO. 61 M C A 47 H. T. S NO. 3004.90.9230 ANDA NO. 205006 THERAPEUTICE USE LACOSAMIDE TABLETS ARE INDICATED AS ADJUNCTIVE THERAPY IN THE TREATMENT OF XXXXXXXXXXXX SEIZURES IN PATIENTS WITH EPILEPSY AGED 17 YEARS AND OLDER. LACOSAMIDE TAB 200MG 60 NDC CODE68462068160 FDA XXXXXXXX ANDA NO. 205006 THERAPEUTICE USE LACOSAMIDE TABLETS ARE INDICATED AS ADJUNCTIVE THERAPY IN THE TREATMENT OF XXXXXXXXXXXX SEIZURES IN PATIENTS WITH EPILEPSY AGED 17 YEARS AND OLDER. COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXX4 DT. 31.08.2026 GROSS WT.3601.966 KGS NET WT.2831.342 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE RANGE 15 DEGREES TO 25 XXXXXXXXXXXXXXXXXXXXXXXXXXXX | GLENMARK PHARMACEUTICALS INC., USA | 美国 | $0 |
| 2026-09-18 | 40 PACKAGES 2070 CARTONS PHARMACEUTICALS AS UNDER NORGESTEE TAB 0.250.035MG 84 NDC CODE68462030929 FDA XXXXXXXXXXXX NO. 65 J D A 27 H.T. S NO. 3006.60.00.00 ANDA NO. 200538 THERA PEUTICE USE ORAL CONTRACEPTIVES ALYACEN 135TAB 10.035MG 84 NDC CODE68462039429 FDA PROD UCT CODE NO. 65 J D A 24 H. T. S NO. 3006.60. 00.00 ANDA NO. 091634 THERAPEUTICE USE ORALCONTRACEPTIVE ESTRADIOL VAG INSERTS 10MCG 8 NDC CODE68462071171 FDA XXXXXXXXXXXX NO. 64 G CA 28 H. T. S NO. 3006.60.00.00 ANDA NO.21026 4 THERAPEUTICE USETHE TREATMENT OF ATROPIC VAGINITIS DUE TO XXXXXXXXX. COMMERCIAL CUSTOMINVOICE NO. XXXXXXXXXXXX DT. 24.08.2026 F227 52002247 DT. 25.08.2026 F22752002255 DT. 25.0 8.2026 GROSS WT.6985.760 KGS NET WT.5341.900KGS 02 DATA LOGGERS SET TEMPERATURE 18 DE GREES SBILL NO 6217130 DT 24AUG2026 SBILL NO 6262396 DT 25AUG2026 XXXXXXXXXXXXXXXXXXXXXX | GLENMARK PHARMACEUTICALS INC., USA | 美国 | $0 |
| 2026-09-18 | 其他零售药品 | GLENMARK PHARMACEUTICALS INC., USA | 美国 | $0 |
| 2026-09-18 | 其他零售药品 | GLENMARK PHARMACEUTICALS INC., USA | 美国 | $0 |
| 2026-09-09 | 41 PACKAGES 1979 CARTONS PHARMACEUTICALS AS UNDER HEATHER TAB 0.35MG 84 NDC CODE68462030329 FDA XXXXXXXXXXXX NO. 65 J C A 24 H. T. S NO. 3006.60.00.00 ANDA NO.90454 THERAPEUTICE USE PREVENTION OF PREGNANCY. DROSPIRENONEEE TAB 30.02MG 84 NDC CODE68462072029 FDA XXXXXXX00 ANDA NO. 204296 THERAPEUTICE USE ORAL CON TRACEPTIVE COMMERCIAL CUSTOM INVOICE NO. F22752002338 DT. 31.08.2026 F22752002342 DT. 31.08.2026 SBILL NO 6428907 DT 31AUG2026 SBILL NO 6428909 DT 31AUG2026 GROSS WT.5488.430 KGS NET WT.3906.820 KGS 02 DATA LOGGERS HUMIDITY65 SET XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX | GLENMARK PHARMACEUTICALS INC., USA | 美国 | $0 |
| 2026-09-09 | 其他零售药品 | GLENMARK PHARMACEUTICALS INC., USA | 美国 | $0 |
| 2026-09-09 | PART OF FCL 20 PACKAGES 2206 CARTONS PHARMACEUTICALS AS UNDER OLMESARTAN MEDOX TAB 40MG 30 NDC CODE68462043830 FDA XXXXXXXXXXXX NO. 62CCA68 H. T. S NO. 3004.90.9220 ANDA NO. 203281 THERAPEUTICE USE TREATMENT OF HYPERTENSION ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTSTO LOWER BLOOD PRESSURE ATOMOXETINE CAP 25M G 30 NDC CODE68462026730 FDA XXXXXXXXXXXX NO.64 UCA 99 H. T. S NO. 3004.90.92.90 ANDA NO. 079019 THERAPEUTICE USE ATOMOXETINE IS USE D TO TREAT ATTENTIONDEFICIT HYPERACTIVITY DISORDER (ADHD) AS PART OF A TOTAL TREATMENT PLAN INCLUDING PSYCHOLOGICAL SOCIAL AND OTHER TREATMENTS OLMESARTAN MEDOX TAB 40MG 30 NDC CODE68462043830 FDA XXXXXXXXXXXX NO. 62CCA68 H. T. S NO. 3004.90.9220 ANDA NO. 203281 THERAP EUTICE USE TREATMENT OF HYPERTENSION ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS TO LOWERBLOOD PRESSURE COMMERCIAL CUSTOM INVOICE N O. F22752002234 DT. 24.08.2026 F22752002236 DT. 24.08.2026 SBILL NO 6236823 DT 25AUG2026 SBILL NO 6236836 DT 25AUG2026 GROSS WT.5045.385 KGS NET WT.3855.653 KGS 02 DATA LOGGERS H UMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERAXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX | GLENMARK PHARMACEUTICALS INC., USA | 美国 | $0 |
| 2026-09-09 | 其他零售药品 | GLENMARK PHARMACEUTICALS INC., USA | 美国 | $0 |